Tekla Capital Management LLC Abbott Laboratories Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tekla Capital Management LLC holds 552,455 shares of ABT stock, worth $72.5 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares

552,455

Previous 623,855 11.44%

Holding current value

$72.5 Million

Previous $63.2 Million 4.66%

% of portfolio

2.38%

Previous 2.42%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $7.2 Million - $8.02 Million	-71,400 Reduced 11.44%	552,455 $60.2 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $6.7 Million - $7.89 Million	-69,196 Reduced 9.98%	623,855 $63.2 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $9.32 Million - $10.9 Million	-98,000 Reduced 12.39%	693,051 $76.1 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $15.8 Million - $18.3 Million	163,759 Added 26.11%	791,051 $76.5 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $869,126 - $1.05 Million	8,515 Added 1.38%	627,292 $68.2 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $4.05 Million - $4.94 Million	35,500 Added 6.09%	618,777 $73.2 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $8.52 Million - $10.4 Million	-73,761 Reduced 11.23%	583,277 $82.1 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $11 Million - $12.1 Million	-93,959 Reduced 12.51%	657,038 $77.6 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $776,498 - $914,050	7,340 Added 0.99%	750,997 $87.1 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $34 Million - $40.1 Million	312,512 Added 72.48%	743,657 $89.1 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $6.47 Million - $7.05 Million	61,572 Added 16.66%	431,145 $47.2 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $10.7 Million - $13 Million	-116,677 Reduced 24.0%	369,573 $40.2 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1.51 Million - $1.93 Million	19,700 Added 4.22%	486,250 $44.5 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $332,003 - $485,480	-5,285 Reduced 1.12%	466,550 $36.8 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $11.7 Million - $13.1 Million	149,322 Added 46.3%	471,835 $41 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $14.9 Million - $16.1 Million	-181,635 Reduced 36.03%	322,513 $27 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3.43 Million - $4 Million	47,100 Added 10.31%	504,148 $42.4 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $4.33 Million - $5.23 Million	65,329 Added 16.68%	457,048 $36.5 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $14.3 Million - $17.3 Million	-235,300 Reduced 37.53%	391,719 $28.7 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $9.88 Million - $10.9 Million	-171,600 Reduced 21.49%	627,019 $38.2 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $24.3 Million - $26 Million	-452,301 Reduced 36.16%	798,619 $45.6 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $4.73 Million - $5.28 Million	98,400 Added 8.54%	1,250,920 $66.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,152,520	1,152,520 $56 Million

Others Institutions Holding ABT

# of Institutions

3,265

Shares Held

1.31B

Call Options Held

9.64M

Put Options Held

8.27M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Abbott Laboratories Transaction History